Ambev (BUE:ABEV) Research & Development: ARS0 Mil (TTM As of Mar. 2026)


BUE:ABEV Ambev SA BUE:ABEV
76 GF Score
Price ARS14,490.00
GF Value ARS12,483.15
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Ambev Research & Development?

Ambev BUE:ABEV -0.75% 76 Research & Development is ARS0 Mil as of Mar. 2026. GuruFocus rates BUE:ABEV with a GF Score™ of 76/100 and a GF Value™ of ARS12,483.15 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ambev's Research & Development for the three months ended in Mar. 2026 was ARS0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ARS0 Mil.

Ambev  (BUE:ABEV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ambev Research & Development Related Terms

Ambev Research & Development Historical Data

* Premium members only.

The historical data trend for Ambev's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambev Research & Development Chart

Ambev Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ambev Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BUE:ABEV
76GF Score
Ambev SA BUE:ABEV
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambev Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ARS0 Mil mean?
Ambev (BUE:ABEV) has a Research & Development of ARS0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Ambev and its competitors.
Is Ambev's Research & Development too high?
Ambev's current Research & Development is ARS0 Mil. Overall, Ambev has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambev's Research & Development compare to STZ and TAP?
Ambev's Research & Development of ARS0 Mil can be compared against companies in the Beverages - Alcoholic industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Beverages - Alcoholic company?
A good Research & Development depends on the Beverages - Alcoholic industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ambev and its competitors. Ambev's current Research & Development is ARS0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambev stock overvalued right now?
Based on GuruFocus' analysis, Ambev (BUE:ABEV) is currently considered Modestly Overvalued. The stock's GF Value™ is ARS12,483.15, compared to a current price of ARS14,490.00 — trading 16.1% above its estimated fair value. The current Research & Development is ARS0 Mil. Ambev's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ambev (BUE:ABEV), the current Research & Development is ARS0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambev (BUE:ABEV) Overvalued in 2026?

Based on GuruFocus' analysis, Ambev stock appears to be overvalued. The current stock price of ARS14,490.00 is trading 16.1% above its estimated GF Value™ of ARS12,483.15. GuruFocus considers Ambev to be Modestly Overvalued.

Key valuation signals for BUE:ABEV:

  • Research & Development: ARS0 Mil
  • GF Value™: ARS12,483.15 vs. price of ARS14,490.00 (16.1% above fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the BUE:ABEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambev Business Description

Address Rua Doctor Renato Paes de Barros, 1017, 4th Floor, Sao Paulo, SP, BRA, 04530-001
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
76GF Score

Get the complete analysis for BUE:ABEV

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS14,490.00
Price
ARS12,483.15
GF Value